We investigated whether mutations in the gene encoding the phosphatidylinositol @-kinase ( PI@K ) catalytic subunit ( PIK@CA ) correlates with response to neoadjuvant human epidermal growth factor receptor @ ( HER@ ) - targeted therapies in patients with breast cancer .